Followers | 79 |
Posts | 24,556 |
Boards Moderated | 1 |
Alias Born | 09/08/2000 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LIDR - 1.62/1.63 Up from 1.20
AEye shares are trading higher after the company disclosed a partnership with LITEON Technology Corporation.
NVAX - 9.52/9.53 Up from 4.47
MW Novavax shares double on Sanofi's $1.4 billion investment for combo vaccine
Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erases Doubts About Its Going Concern
Stocks with buying interest early AM:
NVAX
LIDR
AEMD
WISA
SRTS
SOUN
SGBX
CLSK
MNDR
RNAZ
1.69/1.70 Up .50 with volume coming in.
DJ Notable Labs Price Target Maintained With a $9.00/Share by JMP Securities
SGD - .745/.7413 Up from .62 .....volume coming in now
Safe and Green Development Corporation Inks Partnership to Provide Mortgage Services via the Xene Platform Across 49 States in the U.S
XFOR - 1.09/1.10 Up from 1.04
Press Release: X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
NUWE - .30 Volume coming in.
TAOP - 1.14/1.15 Up from .795
Taoping Launches New Enhanced AI-Powered Smart Terminal
Stocks with buying interest early AM:
IVP
XFOR
AGBA
NUTX
HIMX
INOD - 9.33 Up 2.62
--Innodata Rises Pre-Bell After Swing to Q1 Net Income Amid Higher Sales, 2024 Organic Revenue Growth Outlook Lifted
RPTX - 3.77 up .49
--Repare Therapeutics Shares Rise Premarket Wednesday After Company Swings to Q1 Net Income Amid Higher Revenue
TIVC - 1.49 Up .43
Tivic Health Announces Completion Of Non-Invasive VNS Study Demonstrating Effective Biological Changes In The Autonomic, Cardiac, And Central Nervous Systems
REBN - 3.65 Up 1.90
Reborn Coffee shares are trading higher after the company announced a significant expansion into the China market through a strategic Master License Agreement with IAID Co.
Stocks with buying interest early AM:
SLNH
ISUN
ENVB
CLOV
HSDT
FRSX
INOD
PERI
MTC - 3.17/3.20 Up from 2.30
TCBP - 1.56/1.57 Up from 1.45
TC BioPharm shares are trading higher after the company announced the execution of a non-binding letter of intent to acquire a company pursuing the development of innovative CAR-T therapies for the treatment of refractory cancers and solid tumors.
FGEN - 1.35/1.36 Up from 1.16
FibroGen Q1 2024 GAAP EPS $(0.33) Misses $(0.31) Estimate, Sales $55.902M Beat $36.666M Estimate
CMND - 1.68/1.69 Up from 1.17
Clearmind Medicine Signs Exclusive Patent Licensing Agreement With Yissum Research Development Company; Under Agreement, Clearmind Receives Exclusive Rights To Develop, Manufacture, And Commercialize Novel Compounds For Treating PTSD And Other Mental Health Disorders
More Stocks with buying interest early AM:
CMND
NUWE
EVGO
HRTX
ZKIN
IBRX
Stocks with buying interest early AM:
AIRE
FGEN
TCBP
BURU - .2812/.283 Up from .23
Nuburu Inc Awarded $850,000 Phase II Contract With NASA For Blue Laser Space Technology, Co's To Demonstrate Feasibility Of Surface Power Management Solutions Using Blue Laser Technology
TCBP - 1.91/1.93 Up from 1.46
TC BioPharm Announces Execution Of Second Non-Binding LOI For Acquisition, Targeting Innovative CAR-T Therapies; Financial Terms Not Disclosed
ALLR - 1.17/1.18 Up from 1.00
Allarity Therapeutics shares are trading higher after the company announced that its stockholders' equity is significantly above the $2.5 million minimum required by Nasdaq Listing Rule and will submit a request to the SEC to withdraw Form S-1.
LILM - 1.15/1.16 Up from 1.04
Lilium Announces Firm Order of 20 Lilium Jets from U.S. Operator UrbanLink
PSTV - 2.06/2.07 Up from 1.80
Press Release: Plus Therapeutics Announces Private Placement Financing of up to $18 Million
Stocks with buying interest early AM:
BENF
GRFX
SBFM
LILM
WULF
CTMX
SGBX - 3.68/3.71 Up from 2.93
Safe & Green Holdings' Subsidiary, SG Echo, Is Preparing To Deliveral Its Modular Unit To A Prominent Quick-Service Restaurant Customer In The Pacific Northwest
ROMA - .83/.84 Up from .711
IBRX - 9.45/9.50 Up from 8.97
ImmunityBio shares are trading higher after the company announced it signed an exclusive global arrangement with the Serum Institute of India. The company will be supplied with Bacillus Calmette-Guerin.
HSDT - 3.73/3.74 Up from 2..66
Helius Medical Technologies Expands Stroke Clinical Program With Participation Of Shepherd Center
Stocks with buying interest early AM:
HSDT
HCTI
FUBO
ARDX
ORGN
SBFM
PLUG
IBRX
NUWE - .2352/.2370 UP .1051
Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
SGBX - 3.20 Up 3.10
Safe and Green Holdings Announces Collaboration and Sales of Modular Units to Britten Inc.
ORGO - 2.73/2.80 UP from 2.51
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis
ASNS - .92/.9209 Up from .7899
Actelis Receives $2.3M Order For Immediate Delivery Of New Hybrid-Fiber Intelligent Networking Solution For Washington D.C.'s Department Of Transportation
HUBC - 1.21/1.22 Up from 1.05
HUB Cyber Security shares are trading higher after the company was awarded a $2M contract by the Israeli Airports Authority.
CNTX - 1.84/1.85 Up from 1.36
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
Context Therapeutics Announces $100 Million Private Placement
ALLR - 2.97/2.98 Up from 1.37
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
Stocks with buying interest early AM:
ALLR
CNTX
APVO
HUBC
ORGO
KSCP
RIOT
SOUN
BLNK
WULF
PALI - 8.57/8.65 Up from 6.03
Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)